BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 11, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Nov. 2, 2021

Nov. 2, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 7 Hills, Aldeyra, Astrazeneca, Aurinia, Axon, Clene, Compass, Equillium, Huyabio, Hyloris, Metacrine, Oncoresponse, Primmune, Rhythm, Uniqure, Vicore.
Read More

In the clinic for Nov. 1, 2021

Nov. 1, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apollo Endosurgery, Icecure.
Read More

In the clinic for Nov. 1, 2021

Nov. 1, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzheon, Astrazeneca, Atai, Cabaletta, Calithera, Centessa, Corium, Daiichi, Eiger, Hutchmed, Idorsia, Janssen, Merck, Neurocrine, Novatek, Rhizen, Rivus, Teva, Todos.
Read More

In the clinic for Oct. 29, 2021

Oct. 29, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Roche.
Read More

In the clinic for Oct. 29, 2021

Oct. 29, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Alnylam, Alphamab, Alzinova, Arca, Candel, Context, Edgewise, Hutchmed, Immunic, Inventiva, Landos, Meissa, Optinose, Rafael, Paxmedica, Revolo, Sorrento, Talaris.
Read More

In the clinic for Oct. 28, 2021

Oct. 28, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Align Technology.
Read More

In the clinic for Oct. 28, 2021

Oct. 28, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABVC, Angion, Aptinyx, Biohaven, Context, Cortexyme, Dilafor, GSK, Immunic, Inflarx, Kezar, Kymera, Merck, Moderna, Monopar, Nurix, Sensorion, Springworks, Vifor.
Read More

In the clinic for Oct. 27, 2021

Oct. 27, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Personalis, Sinomed.
Read More

In the clinic for Oct. 27, 2021

Oct. 27, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Alkermes, Aptevo, Canbridge, Esocap, Gilead, Humanigen, Krystal, Merck, Revive, Seres, SQZ, Ultimovacs, Vaxart.
Read More

In the clinic for Oct. 19-25, 2021

Oct. 26, 2021
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Alphamab Oncology, Alterity, Atea, Biontech, Bridge, Cardiol, Crescendo Biologics, Edesa, Entasis, Genfleet, Harbour Biomed, Helixmith, Immune Biosolutions, Opthea, Pfizer, Reven, Senhwa, Statera, Synairgen, Telix, Valneva, Zai Lab.
Read More
Previous 1 2 … 217 218 219 220 221 222 223 224 225 … 328 329 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing